Newsroom
January 20, 2023
With more than 50 studies, departments and centers, the Center for Brain Health at The University of Texas Health Science Center at San Antonio will be home to the institution’s many brain health initiatives. It will include an imaging suite and a non-oncology infusion suite for patient care and clinical trials.
January 19, 2023
Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu With more than 50 studies, departments and centers, the Center for Brain Health at The University of Texas Health Science Center at San Antonio will be home to the institution’s many brain health initiatives. For a complete overview of these vital programs, visit https://advancingbrainhealth.org/. Recently, UT Health San Antonio received […]
January 11, 2023
Kathleen Schock doesn’t claim to be an art expert. But in her elegantly comfortable home filled with her sister-in-law’s artwork, she points out a favorite piece as it reflects the afternoon sun, changing at every angle. She recalled that four years ago, Jim, her husband of 51 years, was diagnosed with dementia. But like […]
January 11, 2023
Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu Statement from the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio about a timely topic in the news: The U.S. Food and Drug Administration on Friday, Jan. 6, 2023, approved lecanemab, a drug that targets the basic pathophysiology of Alzheimer’s disease. The FDA action is […]
January 6, 2023
Researchers discover toxic process involving ‘jumping genes’ Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (Jan. 6, 2023) — Scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) today reported that an inflammatory trigger like one present during viral infections is elevated in Alzheimer’s disease and progressive supranuclear palsy, […]
January 4, 2023
Researchers at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases are researching early indicators of diseases to either prevent or delay the onset of severe symptoms.
